The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bruker Corp's Score
Industry at a Glance
Industry Ranking
114 / 210
Overall Ranking
233 / 4621
Industry
Healthcare Equipment & Supplies
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Buy
Current Rating
44.612
Target Price
+18.21%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Bruker Corp Highlights
StrengthsRisks
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.02% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 26.70%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 26.70%.
Overvalued
The company’s latest PE is 69.45, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 128.10M shares, decreasing 5.97% quarter-over-quarter.
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.